Product Information
ELMIRON 100 MG CAPSULE is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $12.0964 per EA under NDC 50458009801. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 26, 1996.
Strength
100 mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458009801
Classification
Brand
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PENTOSAN POLYSULFATE SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA020193FDA Approved
9/26/1996
On Market Since
9/26/1996
Pharmacological Classes
Price Statistics
The NADAC for ELMIRON 100 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 118.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.0964 per EA |
|---|---|
| All-time high | $12.1083 (Jun 10, 2026) |
| All-time low | $5.5276 (Nov 28, 2013) |
| 52-week high | $12.1083 |
| 52-week low | $11.4743 |
| Median price | $9.0150 |
| Average price | $8.9683 |
| Largest weekly change | +9.9% (Jan 14, 2015) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PENTOSAN POLYSULFATE SODIUM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Janssen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
PENTOSAN POLYSULFATE SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ELMIRON 100 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ELMIRON 100 MG CAPSULE, manufactured by Janssen Pharmaceuticals Inc., is $12.0964 per EA (NDC 50458009801), effective Sep 30, 2026.
How has the price of ELMIRON 100 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ELMIRON 100 MG CAPSULE has risen 118.8%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ELMIRON 100 MG CAPSULE?
Since Nov 28, 2013, the NADAC for ELMIRON 100 MG CAPSULE has ranged from a low of $5.5276 (Nov 28, 2013) to a high of $12.1083 (Jun 10, 2026), with a median of $9.0150 per EA.
Are there cheaper alternatives to ELMIRON 100 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of ELMIRON 100 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ELMIRON 100 MG CAPSULE?
ELMIRON 100 MG CAPSULE (NDC 50458009801) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.